Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

USFDA completes audit at Dr. Reddy’s API Srikakulam Plant

Date: 04-06-2018

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Srikakulam Plant (SEZ), Andhra Pradesh with no observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.